Concepedia

Kai Kang

KK

Statistics

Publications

14

Citations

432

H-Index

12

Active since

2003

Affiliations

Kanion Pharmaceutical (China)(Current)

Northeast Agricultural University

First Hospital of China Medical University

China Medical University

Harbin Medical University

Kai Kang is an author at Kanion Pharmaceutical (China) specializing in life sciences, inflammation, and immunology.

ORCID

Publications per year

2003–2026

14

Publications

14

FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress

Kai Kang, Pengfei Xu, Mengxia Wang et al. · Biomedicine & Pharmacotherapy · 2020 · 119 citations · Full text

, , +17

Arctigenin Attenuates Learning and Memory Deficits through PI3k/Akt/GSK-3β Pathway Reducing Tau Hyperphosphorylation in Aβ-Induced AD Mice

Yue Qi, Deqiang Dou, Hong Jiang et al. · Planta Medica · 2016 · 48 citations · Full text

, , +17

Effects of cyclo (his–pro) plus zinc on glucose metabolism in genetically diabetic obese mice

In-Kyung Hwang, V. L. W. Go, Diane M. Harris et al. · Diabetes Obesity and Metabolism · 2003 · 35 citations

, , +16

Tea polyphenols protect mice from acute ethanol-Induced liver injury by modulating the gut microbiota and short-chain fatty acids

Yue Sun, Kai Kang, Yiling Li et al. · Journal of Functional Foods · 2021 · 33 citations · Full text

, , +17

FGF21 alleviates chronic inflammatory injury in the aging process through modulating polarization of macrophages

Kai Kang, Anran Xia, Fanrui Meng et al. · International Immunopharmacology · 2021 · 31 citations

, , +14

1–5 of 14